Filing Flows › GSK (GSK) › Operating margin
GSK (GSK) operating margin by quarter
GSK's operating margin was 23.9% in Q3 2026 (third quarter 2026), +18.2 pts from Q2 2026. Over the last 5 quarters it ranged from 5.7% (Q2 2026) to 30.3% (Q3 2025).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 23.9% | +18.2 pts | -6.4 pts |
| Q2 2026 | 5.7% | -24.3 pts | -19.6 pts |
| Q1 2026 | 30.1% | -0.3 pts | — |
| Q3 2025 | 30.3% | +5.0 pts | — |
| Q2 2025 | 25.3% | — | — |
Q3 2026 at a glance
GSK, Q3 2026: revenue $8.9B (+4% year over year), operating margin 23.9%, net earnings $1.5B, operating cash flow $3.1B. The chart follows the revenue to costs, profit and cash.
Questions
What is GSK's operating margin?
GSK's operating margin was 23.9% in Q3 2026 (third quarter 2026), +18.2 pts from Q2 2026.
How has GSK's operating margin changed?
Over the last 5 quarters it ranged from 5.7% (Q2 2026) to 30.3% (Q3 2025).